Formation of Advanced Glycation Endproducts from Low Molecular Weight Model Compounds

The process of glycation was studied in 12 model systems containing carbohydrates (Glc, Fru) and peptides (Gly-Gly, Gly-Phe, Phe-Gly, Gly-Lys) or acetylated amino acids (Ac-Lys, Ac-Arg) in order to clarify the role of different structural elements of the reacting components. The course of reaction was followed by the changes of the UV spectra of the reaction systems. The results show that the reactivity of the NH₂ group correlates with its pK_a value. The presence of benzene ring in the amino component accelerates glycation. Strong correlation between the intensity of the fluorescence and the absorption at 325 nm was found for all reaction systems.     

Purification and Characterization of Trochus radiatus Derived Low Molecular Weight Bactericidal Polypeptide Active Against ESKAPE Pathogens

International Journal of Peptide Research and Therapeutics - Antimicrobial peptides comprise core components of innate defense and act as first-line defense molecules in most marine mollusks....     

Inhibition of the p53-hdm2 Interaction with Low Molecular Weight Compounds

The hdm2 protein, upon binding to p53, inhibits its tumour suppressor activity. The inhibition of the p53-hdm2 interaction represents therefore a new therapeutic strategy to activate wild type p53 in tumours. Potent low molecular weight compounds inhibiting this protein-protein interaction, which are active in vivo, have just been identified. This offers new perspectives and hopes in this research area.     

The Apo-structure of the Low Molecular Weight Protein-tyrosine Phosphatase A (MptpA) from Mycobacterium tuberculosis Allows for Better Target-specific Drug Development

Protein-tyrosine phosphatases (PTPs) and protein-tyrosine kinases co-regulate cellular processes. In pathogenic bacteria, they are frequently exploited to act as key virulence factors for human diseases. Mycobacterium tuberculosis, the causative organism of tuberculosis, secretes a low molecular weight PTP (LMW-PTP), MptpA, which is required for its survival upon infection of host macrophages. Although there is otherwise no sequence similarity of LMW-PTPs to other classes of PTPs, the phosphate binding loop (P-loop) CX₅R and the loop containing a critical aspartic acid residue (D-loop), required for the catalytic activity, are well conserved. In most high molecular weight PTPs, ligand binding to the P-loop triggers a large conformational reorientation of the D-loop, in which it moves ∼10 Å, from an “open” to a “closed” conformation. Until now, there have been no ligand-free structures of LMW-PTPs described, and hence the dynamics of the D-loop have remained largely unknown for these PTPs. Here, we present a high resolution solution NMR structure of the free form of the MptpA LMW-PTP. In the absence of ligand and phosphate ions, the D-loop adopts an open conformation. Furthermore, we characterized the binding site of phosphate, a competitive inhibitor of LMW-PTPs, on MptpA and elucidated the involvement of both the P- and D-loop in phosphate binding. Notably, in LMW-PTPs, the phosphorylation status of two well conserved tyrosine residues, typically located in the D-loop, regulates the enzyme activity. PtkA, the kinase complementary to MptpA, phosphorylates these two tyrosine residues in MptpA. We characterized the MptpA-PtkA interaction by NMR spectroscopy to show that both the P- and D-loop form part of the binding interface.     

The Behavior of Low Molecular Weight Organic Carbon-14 Containing Compounds in Contaminated Groundwater During Denitrification and Iron-Reduction

Abstract

Aqueous low molecular weight organic carbon-14 (¹⁴C) substances can be formed by the oxidation of carbide and impurities within nuclear fuel cladding. During reprocessing and interim storage ¹⁴C-labeled organic compounds may leak to the shallow subsurface environments at nuclear facilities where denitrifying and iron reducing zones can exist. ¹⁴C-labeled organic compounds (acetate, formate, formaldehyde and methanol) were used as electron donors in microcosm experiments, under both denitrification and iron reduction, using glacial outwash sediments and groundwater composition representative of the Sellafield nuclear reprocessing site, UK. In denitrifying microcosms, <6% of the initial ¹⁴C-DOC remained 15?days after injection into the microcosm irrespective of the electron donor; with concurrent ¹⁴CO2 (g) production. Lack of removal in sterile controls suggests that ¹⁴C-organics were metabolized by microorganisms. Under iron-reducing conditions both ¹⁴C-carboxylates were removed from solution rapidly, but some formaldehyde and methanol remained in solution 32?days after injection into the microcosm so there is potential that a proportion of ¹⁴C-formaldehyde and ¹⁴C-methanol may persist for longer in subsurface environments.     

The Metabolism of Low Molecular Weight Hydrocarbon Gases in Man

The metabolism of ethane and pentane in man is demonstrated to occur from the uptake of an enriched atmosphere of these gases in a rebreathe spirometer circuit. Dithiocarb, an inhibitor of alkane metabolism, reduced uptake and increased the respiratory excretion of these gases. This effect was least marked for the slowly metabolised ethane. Therefore the endogenous production of ethane as measured by respiratory excretion is less affected. However pentane is rapidly metabolised and this limits the use of simple respiratory excretion of pentane as a measure of in vivo lipid peroxidation.     

Molecular mechanisms regulating persistent Mycobacterium tuberculosis infection

Establishing persistent infection and resisting elimination by the host's immune system are key factors contributing to latent infection by Mycobacterium tuberculosis. Recently, bacterial determinants regulating these processes have been identified. Here, we review molecular mechanisms regulating persistent infection and discuss the highly dynamic interaction of M. tuberculosis with the host.     

Molecular model of shikimate kinase from Mycobacterium tuberculosis

Tuberculosis (TB) resurged in the late 1980s and now kills approximately 3 million people a year. The reemergence of tuberculosis as a public health threat has created a need to develop new anti-mycobacterial agents. The shikimate pathway is an attractive target for herbicides and anti-microbial agents development because it is essential in algae, higher plants, bacteria, and fungi, but absent from mammals. Homologs to enzymes in the shikimate pathway have been identified in the genome sequence of Mycobacterium tuberculosis. Among them, the shikimate kinase I encoding gene (aroK) was proposed to be present by sequence homology. Accordingly, to pave the way for structural and functional efforts towards anti-mycobacterial agents development, here we describe the molecular modeling of M. tuberculosis shikimate kinase that should provide a structural framework on which the design of specific inhibitors may be based.     

结核分枝杆菌耐吡嗪酰胺分子机制研究

吡嗪酰胺(PZA)是结核病短程化疗中的一线抗结核药物,由吡嗪酰胺酶转换成为活性形式吡嗪酸而生效。吡嗪酰胺酶由pncA基因编码,pncA基因突变会导致该酶活性丧失,与PZA耐药性产生有关。为了进一步明确PZA耐药性产生的基因学基础和PZA耐药株的pncA基因突变率,对中国100株结核分枝杆菌临床分离株进行了DNA序列测定,其中85株为PZA耐药株,15株为PZA敏感株。PZA耐药株有27%(23/85)发生了pncA基因突变,从而导致吡嗪酰胺酶基本氨基酸序列的改变,突变分布在pncA基因开读框架17-546位的核苷酸。其中有一株突变位于pncA基因的调节区域-11位处。同时发现20%(3/15)pncA敏感株也发生了pncA基因突变。敏感株发生突变可能是由于PZA敏感性实验不准确或存在其它耐药机制。实验表明,pncA基因突变是PZA耐药的主要机制之一,中国PZA耐药临床分离株尚存在其它耐药分子机制。